{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:58:29Z","timestamp":1774407509308,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2012ZX09401008"],"award-info":[{"award-number":["2012ZX09401008"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province","doi-asserted-by":"publisher","award":["BE2015016"],"award-info":[{"award-number":["BE2015016"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejps.2017.09.021","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T06:30:18Z","timestamp":1505284218000},"page":"624-630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Recombinant humanized anti-vascular endothelial growth factor monoclonal antibody efficiently suppresses laser-induced choroidal neovascularization in rhesus monkeys"],"prefix":"10.1016","volume":"109","author":[{"given":"Wan-Wan","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-An","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Sheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.09.021_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2016.04.003","article-title":"Retinal ganglion cell layer change in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"167","author":"Beck","year":"2016","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.ejps.2017.09.021_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ejps.2017.09.021_bb0015","series-title":"Lable for EYLEA\u00ae (Aflibercept) Injection","author":"FDA","year":"2016"},{"key":"10.1016\/j.ejps.2017.09.021_bb0020","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejps.2017.09.021_bb0025","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejps.2017.09.021_bb0030","article-title":"Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2017.09.021_bb0035","article-title":"VEGF receptor blockade markedly reduces retinal microglia\/macrophage infiltration into laser-induced CNV","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2017.09.021_bb0040","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2017.09.021_bb0045","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archophthalmol.2011.210","article-title":"Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates","volume":"129","author":"Nork","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejps.2017.09.021_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10456-013-9398-x","article-title":"In vitro and ex vivo retina angiogenesis assays","volume":"17","author":"Rezzola","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejps.2017.09.021_bb0055","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jpba.2008.09.020","article-title":"Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products","volume":"48","author":"Shankar","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2017.09.021_bb0060","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.1038\/srep11333","article-title":"Production of monoclonal antibodies against GPCR using cell-free synthesized GPCR antigen and biotinylated liposome-based interaction assay","volume":"5","author":"Takeda","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejps.2017.09.021_bb0065","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archopht.1996.01100140172010","article-title":"Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate","volume":"114","author":"Tolentino","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejps.2017.09.021_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejps.2017.09.021_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156716","article-title":"AGIA tag system based on a high affinity rabbit monoclonal antibody against human dopamine receptor D1 for protein analysis","volume":"11","author":"Yano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2017.09.021_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01739641","article-title":"Vascular endothelial growth factor expression in choroidal neovascularization in rats","volume":"235","author":"Yi","year":"1997","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejps.2017.09.021_bb0085","series-title":"A Humanized Anti-VEGF Rabbit Monoclonal Antibody Inhibits Angiogenesis and Blocks Tumor Growth in Xenograft Models","volume":"Vol. 5","author":"Yu","year":"2010"},{"key":"10.1016\/j.ejps.2017.09.021_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2013.06.007","article-title":"Development of humanized rabbit monoclonal antibodies against vascular endothelial growth factor receptor 2 with potential antitumor effects","author":"Yu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2017.09.021_bb0095","first-page":"37","article-title":"Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys","volume":"14","author":"Zhang","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejps.2017.09.021_bb0100","series-title":"Cedilanid Inhibits Retinal Neovascularization in a Mouse Model of Oxygen-induced Retinopathy","first-page":"346","author":"Zhang","year":"2017"},{"key":"10.1016\/j.ejps.2017.09.021_bb0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11095-008-9718-9","article-title":"The pharmacology study of a new recombinant human VEGF receptor-Fc fusion protein on experimental choroidal neovascularization","volume":"26","author":"Zhang","year":"2009","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717305134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717305134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T18:31:17Z","timestamp":1535394677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717305134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":21,"alternative-id":["S0928098717305134"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.09.021","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant humanized anti-vascular endothelial growth factor monoclonal antibody efficiently suppresses laser-induced choroidal neovascularization in rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}